- Report
- May 2024
- 137 Pages
Global
From €6377EUR$6,499USD£5,303GBP
Rhofade is a topical cream used to treat persistent facial redness due to rosacea. It is a prescription medication that works by blocking the action of certain chemicals in the body that cause redness. It is the first and only topical cream approved by the U.S. Food and Drug Administration (FDA) to treat persistent facial redness due to rosacea. The active ingredient in Rhofade is oxymetazoline hydrochloride, a vasoconstrictor that works by narrowing the blood vessels in the skin.
The Rhofade market is a growing segment of the dermatological drugs market. It is a relatively new product, but has seen increasing demand due to its effectiveness in treating persistent facial redness. It is a highly competitive market, with several companies offering similar products.
Some of the companies in the Rhofade market include Allergan, Galderma, and Merz Pharmaceuticals. Allergan is the maker of Rhofade, while Galderma and Merz Pharmaceuticals offer similar products. Allergan also offers a generic version of Rhofade, which is available at a lower cost. Show Less Read more